← 홈

ADC

11개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 11개
ADCBHotBiologicAstraZenecavedotin plus PD-1 blockade …Phase 3

GEM (Gemcitabine, Gemcitabine (GEM))

Extranodal NK/T-cell Lymphoma · Nasopharyngeal Carcinoma (NPC)

#NasopharyngealCarcinomaNPC#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 50%임상시험 190상태 RECRUITING
ADCBHotBiologicK-Group, Beta, Inc., a wholly o…atPhase 3

Gemcitabine Hydrochloride (Gemcitabine Hydrochloride)

Clear Cell Adenocarcinoma; Fallopian Tube Clear Cell Adenocarcinoma · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 50%임상시험 135상태 RECRUITING
ADCBiologicstaleAstraZenecaVedotin in a Hemodialysis P…Phase 3

Gemcitabine/Carboplatin (Gemcitabine/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 69.6%임상시험 67상태 ACTIVE
ADCBiologicstaleAmer Zureikatvedotin after avelumabPhase 2

Gemcitabine (Gemzar, Gemzar (Gemcitabine))

Pancreatic Cancer · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase2#인기#항체약물접합체+5
임상시험 62상태 DISCONTINUED
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 1

Gemcitabine/Cisplatin II (Gemcitabine/Cisplatin II)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#인기#항체약물접합체+2
효능 ORR 72%임상시험 60상태 ACTIVE
ADCBiologicstaleClovis Oncology, Inc.vedotin after avelumabPhase 1

Gemcitabine/Cisplatin I (Gemcitabine/Cisplatin I)

Muscle Invasive Bladder Urothelial Carcinoma · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 45.2%임상시험 55상태 ACTIVE
ADCBiologicstaleRemeGenApproved

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin and Gemcitabine)

Radical Cystectomy; Urothelial Carcinoma · Radical Cystectomy

#RadicalCystectomy#ADC#Approved#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 ACTIVE
ADCBiologicstalePeking University Third HospitalPhase 2

Chemotherapy (Gemcitabine, Gemcitabine (Chemotherapy))

Muscle-Invasive Bladder Cancer (MIBC) · Muscle-Invasive Bladder Cancer (MIBC)

#Muscle-InvasiveBladderCancerMIBC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleWest China HospitalPhase 3

Gemcitabine + Cisplatin（GC）+Toripalimab (Gemcitabine + Cisplatin（GC）+Toripalimab)

Urinary Bladder Neoplasms · Urinary Bladder Neoplasms

#UrinaryBladderNeoplasms#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleRochePhase 2

Glofitamab, Polatuzumab Vedotin, Gemcitabine, and Oxaliplatin as Induction Therapy (Glofitamab, Polatuzumab Vedotin, Gemcitabine, and Oxaliplatin as Induction Therapy)

Aggressive B-Cell Lymphoma · Aggressive B-Cell Lymphoma

#AggressiveB-CellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleOncomatryx Biopharma S.L.Phase 1

Nab-paclitaxel + Gemcitabine (Nab-paclitaxel + Gemcitabine)

Pancreatic Adenocarcinoma Metastatic · Pancreatic Adenocarcinoma Metastatic

#PancreaticAdenocarcinomaMetastat#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING